Follow
Rolf T. Hansen III, Ph.D.
Rolf T. Hansen III, Ph.D.
Teva Pharmaceuticals
Verified email at tevapharm.com - Homepage
Title
Cited by
Cited by
Year
Sleep deprivation causes memory deficits by negatively impacting neuronal connectivity in hippocampal area CA1
R Havekes, AJ Park, JC Tudor, VG Luczak, RT Hansen, SL Ferri, ...
Elife 5, e13424, 2016
2392016
Inhibition of phosphodiesterase-4 decreases ethanol intake in mice
W Hu, T Lu, A Chen, Y Huang, R Hansen, LJ Chandler, HT Zhang
Psychopharmacology 218, 331-339, 2011
792011
Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior
RT Hansen, M Conti, HT Zhang
Psychopharmacology 231, 2941-2954, 2014
542014
Compartmentalized PDE4A5 signaling impairs hippocampal synaptic plasticity and long-term memory
R Havekes, AJ Park, RE Tolentino, VM Bruinenberg, JC Tudor, Y Lee, ...
Journal of Neuroscience 36 (34), 8936-8946, 2016
512016
Senescent-induced dysregulation of cAMP/CREB signaling and correlations with cognitive decline
RT Hansen III, HT Zhang
Brain research 1516, 93-109, 2013
422013
Learning induces the translin/trax RNase complex to express activin receptors for persistent memory
AJ Park, R Havekes, X Fu, R Hansen, JC Tudor, L Peixoto, Z Li, YC Wu, ...
Elife 6, e27872, 2017
362017
The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice
MJ Seminerio, R Hansen, N Kaushal, HT Zhang, CR McCurdy, ...
International Journal of Neuropsychopharmacology 16 (5), 1033-1044, 2013
262013
Phosphodiesterase-4 modulation as a potential therapeutic for cognitive loss in pathological and non-pathological aging: Possibilities and Pitfalls
HTZ Rolf T. Hansen III
Current Pharmaceutical Design, 2014
222014
The past, present, and future of phosphodiesterase-4 modulation for age-induced memory loss
RT Hansen, HT Zhang
Phosphodiesterases: CNS Functions and Diseases, 169-199, 2017
92017
Yclic amp-specific phosphodiesterase-4 pde4: a novel target for alcohol dependence
W Hu, RT Wen, Y Huang, R Hansen, C Wang, M Conti, N Grahame, ...
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 35 (6), 182A-182A, 2011
12011
Targeting PDE4 for Alzheimer’s Disease and Alcoholism: An implication in Alcohol-Related Dementia?
H WANG, F ZHANG, H FU, Y ZHOU, X LIU, X HOU, W HU, R Hansen, ...
神经药理学报 8 (4), 39-41, 2018
2018
Targeting PDE4 Isoforms for Alcoholism and Alzheimer's Disease: An Implication in Alcohol-related Dementia?
HT Zhang, Q Wu, C Wang, R Hansen, Y Jiang, Y Xu, J O'Donnell
NEUROPSYCHOPHARMACOLOGY 40, S298-S298, 2015
2015
Functional characterization of Phosphodiesterase-4A in behavior and obesity
RT Hansen III
West Virginia University, 2014
2014
Disruption of Phosphodiesterase-4 (PDE4) Subtypes to Reduce Ethanol Consumption
Y Jiang, W Hu, Y Huang, R Hansen, Z Meng, M Conti, HT Zhang
Hormone and Metabolic Research 44 (10), A4, 2012
2012
Behavioral phenotype of phosphodiesterase 4A (PDE4A) knockout mice suggests a role in memory and anxiety
R Hansen, Q Wu, C Wang, Y Huang, W Hu, Y Jiang, Z Meng, M Conti, ...
The FASEB Journal 25, lb431-lb431, 2011
2011
Identification of the role of phosphodiesterase in mediating memory: implication in Alzheimer's disease
R HANSEN, M CONTI, SP WILSON, JM O'DONNELL
中国神经科学学会第九届全国学术会议暨第五次会员代表大会论文摘要集, 2011
2011
Behavioral phenotype of PDE4A knockout mice: Implications in anxiety, alcoholism, and depression and memory loss associated with Alzheimer's disease
R Hansen, Q Wu, C Wang, Y Jiang, M Conti, J O'Donnell, HT Zhang
The system can't perform the operation now. Try again later.
Articles 1–17